HomeCase StudiesImporting US and EU sourced comparators into...

Importing US and EU sourced comparators into China.

  • Published 04/11/2019
  • Author Darren Leaver - Global Head, Clinical Trial Supply
  • Division Clinical Trial Supply (CTS)

A large Pharmaceutical company was facing major challenges when importing their centrally sourced comparators into China. Working with their CRO and CMO there was a lack of understanding of the regulatory and import specifications in China, which had caused them to have product held up and import license applications rejected, which ultimately led to them having to delay dosing in the study.

Utilising our global partners and our in-house regulatory expertise, Bionical Emas was able to provide a fully mapped out solution to ensure product was delivered into China. Through working with the manufacturers in the EU, we were able to access the required first leg documentation and other supporting documents (CoA and CoO) to ensure a smooth import license application process. Utilising our partnership with our local broker and logistics partners, Bionical Emas managed the import license application process and successfully received this from the CFDA in 24 hours of receiving all required documents. As a result, our client was able to significantly reduce the delays in the study and ensured a reliable route for future re-supplies.

  • First Leg Documentation and other supporting documents (CoA, CoC) provided

  • Import License and process timeline significantly reduced

  • Complex supply process navigated and guaranteed for future re-supplies

We can support you with…

Clinical Trial Supply

Bionical Emas CTS are a team of dedicated and passionate individuals, providing unrivalled global access to medicines and ancillaries for use in clinical trials. We provide a customized end-to-end supply solution for our clients, using our global network of manufacturers and authorized distributors, underpinned by our market-leading Quality Management System.


How can we support you?

Our dedicated teams of experts are on hand to help should you require any additional resource or further information about our services.

COVID-19 Guidance & Measures

A statement from the Bionical Emas Group on guidance & measures regarding COVID-19 - read here

In relation to staff and visitor safety, we have full risk assessments in place for all of our workplaces. These risk assessments are revisited and updated regularly, to reflect changing risks, knowledge and circumstances, and to reflect evolving Government guidance. We have not placed the risk assessments here on the website as they would become out of date too quickly. However, you are welcome to email info@bionical-emas.com to request access to our most up to date risk assessments applicable to your needs. Please note that all our staff are notified of all applicable risk assessments and updates, along with ‘quick guides’ automatically via our e-learning system.